Detalhe da pesquisa
1.
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis. / Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU).
Gastroenterol Hepatol
; 47(5): 522-552, 2024 May.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-38311005
2.
Use of teduglutide for short bowel syndrome and Crohn's disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy.
Rev Esp Enferm Dig
; 115(6): 331-332, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36177820
3.
Clinical settings with tofacitinib in ulcerative colitis.
Rev Esp Enferm Dig
; 2022 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35373565
4.
Author´s answer to: "Effect of adacolumn® in ulcerative colitis with COVID-19".
Rev Esp Enferm Dig
; 112(6): 511-512, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32496123
5.
COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic.
Rev Esp Enferm Dig
; 112(5): 389-396, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32338017
6.
Questions and answers about the management of Crohn's disease and ulcerative colitis with vedolizumab. / Preguntas y respuestas sobre el manejo de la enfermedad de Crohn y la colitis ulcerosa con vedolizumab.
Gastroenterol Hepatol
; 42(10): 650-656, 2019 Dec.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-31635855
7.
Update of the SEPD position statement on the use of biosimilars for inflammatory bowel disease.
Rev Esp Enferm Dig
; 110(6): 407, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29527903
8.
Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy. / Paciente con enfermedad de Crohn en tratamiento con adalimumab y esteroides que desarrolla aspergilosis pulmonar.
Gastroenterol Hepatol
; 42(6): 387-388, 2019.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-30042000
9.
Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) / Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis
Gastroenterol. hepatol. (Ed. impr.)
; 47(5): 522-552, may. 2024. tab
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-CR-365
10.
[Myiasis caused by Eristalis tenax in Crohn's disease]. / Miasis por eristalis tenax en enfermedad de Crohn.
Gastroenterol Hepatol
; 33(8): 616-7, 2010 Oct.
Artigo
Espanhol
| MEDLINE | ID: mdl-20435382
11.
COVID-19 y aparato digestivo: protección y manejo en la pandemia por SARS-CoV-2 / No disponible
Rev. esp. enferm. dig
; 112(5): 389-396, mayo 2020. ilus, tab
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-188377
12.
Update of the SEPD position statement on the use of biosimilars for inflammatory bowel disease
Rev. esp. enferm. dig
; 110(6): 407-407, jun. 2018.
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-177697
13.
Respuesta de los autores a: "Efecto del Adacolumn® en colitis ulcerosa con COVID-19" / Author's answer to: "Effect of adacolumn® in ulcerative colitis with COVID-19"
Rev. esp. enferm. dig
; 112(6): 511-512, jun. 2020.
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-189800
14.
[Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression]. / Recomendaciones de manejo de la gripe A (H1N1) en pacientes reumáticos con inmunosupresión.
Reumatol Clin
; 6(1): 63-8, 2010.
Artigo
Espanhol
| MEDLINE | ID: mdl-21794681
15.
Preguntas y respuestas sobre el manejo de la enfermedad de Crohn y la colitis ulcerosa con vedolizumab / Questions and answers about the management of Crohn's disease and ulcerative colitis with vedolizumab
Gastroenterol. hepatol. (Ed. impr.)
; 42(10): 650-656, dic. 2019.
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-188199
16.
Paciente con enfermedad de Crohn en tratamiento con adalimumab y esteroides que desarrolla aspergilosis pulmonar / Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy
Gastroenterol. hepatol. (Ed. impr.)
; 42(6): 387-388, jun.-jul. 2019. ilus
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-183796
17.
Uso de teduglutide en intestino corto secundario a enfermedad de Crohn en un paciente con terapia dual ustekinumab y vedolizumab / Use of teduglutide for short bowel syndrome and Crohns disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy
Rev. esp. enferm. dig
; 115(6): 331-332, 2023. ilus
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-221718
18.
Recomendaciones de manejo de la gripe A (H1N1) en pacientes reumáticos con inmunosupresión / Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression
Reumatol. clín. (Barc.)
; 6(1): 63-68, ene.-feb. 2010. ilus
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-78416
19.
Miasis por eristalis tenax en enfermedad de Crohn / Myiasis caused by Eristalis tenax in Crohns disease
Gastroenterol. hepatol. (Ed. impr.)
; 33(8): 616-617, Oct. 2010. ilus
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-85668